Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 18.125
-1.28 %
$ 1.05 B
Market Cap
13.53
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Embecta Corp.
| Revenue | 1.12 B |
| Cost Of Revenue | 388 M |
| Gross Profit | 735 M |
| Operating Expenses | 568 M |
| Operating Income | 167 M |
| Other Expenses | 88.5 M |
| Net Income | 78.3 M |
Income Statement
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 1 123.1 | 1 120.8 | 1 129.5 | 1 165.0 | 1 085.5 | 1 109.0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 387.9 | 370.9 | 354.6 | 365.0 | 322.9 | 323.0 |
| Gross Profit | 735.2 | 749.9 | 774.9 | 800.0 | 762.6 | 786.0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 568.4 | 528.4 | 406.4 | 308.0 | 276.1 | 284.0 |
| Selling, General and Administrative Expenses | 365.1 | 341.3 | 294.8 | 240.0 | 214.7 | 222.0 |
| Research and Development Expenses | 78.8 | 85.2 | 66.9 | 63.0 | 61.4 | 62.0 |
| Operating Income | 166.8 | 221.5 | 309.6 | 492.0 | 486.5 | 502.0 |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 112.3 | 107.0 | 46.2 | 0 | 0 | 0 |
| Total Other Income | (122.6) | (115.8) | (53.0) | 3.0 | (0.7) | (2.0) |
| Pre-Tax Income | 44.2 | 105.7 | 256.6 | 495.0 | 485.8 | 500.0 |
| NET INCOME | ||||||
| Tax Provision | (34.1) | 35.3 | 33.0 | 80.0 | 58.2 | 68.0 |
| Net Income | 78.3 | 70.4 | 223.6 | 414.8 | 427.6 | 432.0 |
| EPS | 1.36 | 1.23 | 3.92 | 7.31 | 7.5 | 7.58 |